Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoyuan Dikang Pharmaceuticals is a Chinese pharmaceutical company based in Liaoyuan, Jilin Province, specializing in the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company produces a wide range of products including tablets, capsules, and granules, with a focus on therapeutic areas such as gastroenterology, cardiovascular health, and respiratory medicine. It operates as a key regional manufacturing hub, adhering to Good Manufacturing Practice (GMP) standards to supply the domestic Chinese market. Its portfolio includes both traditional Chinese medicine (TCM) derivatives and modern chemical drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoyuan Dikang Pharmaceuticals.